Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
4
Global Brain, JIC Venture Growth Investments
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
BioCorteXVenture round $5M · 3 yr ago · 11-50 employees
BioCorteX runs in-silico bridge trials that map how the microbiome changes a drug.
OncobiomixConvertible Note $100k · 1 mo ago · Founded 2023 · 51-200 employees
Precision nutrition for cancer care. Trusted oncology dietitians + microbiome science.
AMILISeries A $10.5M · 4 yr ago · Founded 2019
AMILI runs Southeast Asia's first gut microbiome bank and offers microbiome testing and therapeutic research. Its data addresses the…
Scioto Biosciences IncVenture round $1.8M · 8 yr ago · Founded 2017
Scioto Biosciences is a preclinical stage biotech company dedicated to innovative research and discovery in the field of microbiome…
OutpostPre-Seed $3.5M · 8 mo ago · Founded 2019 · 11-50 employees
Outpost builds AI models of the human microbiome so drug, food, and ingredient R&D teams can predict microbiome interactions and flag risks…
Discover your unique microbiome with InnerBuddies' Microbiome Test. Improve your gut health with personalised advice tailored to your…

Overview

Metagen Therapeutics is a Japanese biotech startup founded by researchers from Juntendo University, Keio University and Tokyo Institute of Technology that focuses on microbiome science. It discovers and develops intestinal microbiome‑based therapeutics and drug candidates targeting various diseases through microbiome analysis and translational research. Its products and programs target clinical and pharmaceutical markets with the goal of creating social impact by improving medical care and advancing drug discovery.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors4
NVCCVia a fund
42 portfolio companies: Rege Nephro, A-SEEDS, Co well and 39 more
69 portfolio companies: Fermelanta, Inc., survbiopharma.co.jp, T1D Scout and 66 more
125 portfolio companies: GMO, Quemix, .JPN.COM and 122 more
Global BrainVia a fund
532 portfolio companies
Show all 4